迪拜孕产妇RSVpreF疫苗接种预防婴儿RSV的预算影响数据集

基于模型评估迪拜孕产妇RSVpreF疫苗预防婴儿RSV-LRTI的预算影响,包含疾病病例、成本和疫苗接种成本数据。

Figshare
2025-07-02 更新
浏览 39
表格Respiratory syncytial virusesmaternally-acquired immunityUnited Arab Emiratesinfantcost analysis疫苗编码
Budget impact of maternal vaccination with RSVpreF to protect privately insured infants in Dubai against respiratory syncytial virus

基本信息

模态
表格
大小
0.0001596 GB
许可
CC BY-NC-ND 4.0
创建/更新时间
2025-07-02
版本
v1

资源简介

迪拜孕产妇RSVpreF疫苗接种预防婴儿RSV的预算影响数据集

【数据集背景】

本数据集源站标题为《Budget impact of maternal vaccination with RSVpreF to protect privately insured infants in Dubai against respiratory syncytial virus》。配套论文《Budget impact of maternal vaccination with RSVpreF to protect privately insured infants in Dubai against respiratory syncytial virus》发表于 Human Vaccines & Immunotherapeutics(2025),DOI:10.1080/21645515.2025.2523106。项目资助方:This study was sponsored by Pfizer. Ahuva Averin, Erin Quinn, and Emily Kutrieb are employees of Avalere Health, which received funding from Pfizer Inc. in connection with the development of this manuscript and this study. Mostafa Zayed, Jean Joury, Amy Law, and Diana Mendes are employed by, and are shareholders of, Pfizer Inc.。源站首次发布:2025-07-02。

【数据内容】

源站原始描述:Respiratory syncytial virus (RSV) manifesting as lower respiratory tract illness (LRTI; RSV-LRTI) represents a significant healthcare burden among infants in Dubai and worldwide. The novel bivalent stabilized prefusion F subunit vaccine (RSVpreF) for administration among pregnant women to protect infants against RSV-LRTI has been evaluated and approved for use in Dubai. We assessed the budget impact of year-round maternal RSVpreF use to prevent RSV-LRTI among privately insured non-Emirati infant…

【数据结构与技术规格】

文件数 3 个,合计 159.60 KB。khvi_a_2523106_sm7758.docx:application/vnd.openxmlformats-officedocument.wordprocessingml.document,47.31 KB。khvi_a_2523106_sm7757.docx:application/vnd.openxmlformats-officedocument.wordprocessingml.document,52.74 KB。khvi_a_2523106_sm7756.docx:application/vnd.openxmlformats-officedocument.wordprocessingml.document,59.54 KB。数据集 DOI:10.6084/m9.figshare.29458627.v1。

【主题与分类】

源站学科分类:Medicine、Cell Biology、Biotechnology、Sociology、Immunology、Mathematical Sciences not elsewhere classified。主题标签:Respiratory syncytial viruses、maternally-acquired immunity、United Arab Emirates、infant、cost analysis。

【适用方向】

结构化表格数据可直接用于统计建模、特征工程与队列分析。

【获取与许可】

源站页面:https://tandf.figshare.com/articles/dataset/Budget_impact_of_maternal_vaccination_with_RSVpreF_to_protect_privately_insured_infants_in_Dubai_against_respiratory_syncytial_virus/29458627

使用许可:CC BY-NC-ND 4.0(https://creativecommons.org/licenses/by-nc-nd/4.0/)。

规范引用:Budget impact of maternal vaccination with RSVpreF to protect privately insured infants in Dubai against respiratory syncytial virus. Taylor & Francis. Zayed, Mostafa; Joury, Jean; Farghaly, Mohamed; Al Dallal, Sara; Mahendiran, Ramya; Law, Amy W.; et al

【使用注意】

· 源站最后修改于 2026-09-15,引用时请注意版本时效。

官方服务

专家保障全链路合规授权与标注交付

陕川双基地 × 超十家三甲医院直连

从合规授权、采集治理、专业标注到数据集交付,我们提供全链路闭环服务,让高质量临床数据即拿即用。

⚡️ 需要原始数据或标注支持?联系我们获取定制方案。

帮我联系

下载信息

注册下载

需要注册 Kaggle 账号并登录后下载,适合需要跟踪下载记录和使用 API 的用户。

暂未开放

公开下载

无需注册即可直接获取公开样本或文档,适合快速预览和评估数据集质量。

免登录

有偿下载

公开数据集受托下载与技术交付服务。

提供高速下载与技术交付服务(收技术服务费,非数据销售)

暂未开放

当前数据集主要来源为 Kaggle 公开托管,完整影像包建议通过原始链接或 Kaggle API 获取。

使用方式

数据集获取(Figshare)

命令行下载

curl -L -o "khvi_a_2523106_sm7758.docx" "https://ndownloader.figshare.com/files/55925954"
curl -L -o "khvi_a_2523106_sm7757.docx" "https://ndownloader.figshare.com/files/55925957"
curl -L -o "khvi_a_2523106_sm7756.docx" "https://ndownloader.figshare.com/files/55925960"

文件清单

  • khvi_a_2523106_sm7758.docx(47.31 KB)
  • khvi_a_2523106_sm7757.docx(52.74 KB)
  • khvi_a_2523106_sm7756.docx(59.54 KB)

文件总体积 159.60 KB(源站 API 实测)。

数据加载示例(图像类)

from PIL import Image
import glob, os

files = (glob.glob(os.path.join(path, "**", "*.png"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.jpg"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.tif"), recursive=True))
print("图像文件数:", len(files))
img = Image.open(files[0]); print("尺寸/模式:", img.size, img.mode)

# torchvision Dataset 方式:
# from torchvision import datasets
# ds = datasets.ImageFolder(path)  # 要求 子目录=类别

目录组织与标注格式以源站说明和下载后实际文件为准。

数据说明

Respiratory syncytial virus (RSV) manifesting as lower respiratory tract illness (LRTI; RSV-LRTI) represents a significant healthcare burden among infants in Dubai and worldwide. The novel bivalent stabilized prefusion F subunit vaccine (RSVpreF) for administration among pregnant women to protect infants against RSV-LRTI has been evaluated and approved for use in Dubai. We assessed the budget impact of year-round maternal RSVpreF use to prevent RSV-LRTI among privately insured non-Emirati infants living in Dubai. A deterministic cohort model was built to illustrate clinical and economic outcomes of RSV-LRTI among infants from birth to age 1 year for five annual birth cohorts. Model population comprised infants born to non-Emirati pregnant women; parameter values were estimated principally based on published sources using Dubai-specific data to the extent possible. Model outcomes included cases of disease (hospital, emergency department, outpatient clinic), disease-attributable deaths, and costs of disease and vaccination (in US$). Budget impact was reported in terms of overall cost and per-member per-year (PMPY) cost. With no intervention, there would be 23,267 RSV-LRTI cases (1,960 hospital; 5,655 emergency department 15,652 outpatient) and medical costs would total $11.5 M over 5 years. Targeting 10% of pregnant women with RSVpreF would prevent 855 cases and reduce infant medical care costs by $0.5 M. With vaccination costs estimated at $3.6 M, overall costs would increase by $3.1 M overall and $0.19 PMPY. Findings suggest that RSVpreF use among pregnant women would substantially reduce the clinical and economic burden of RSV-LRTI in infants, requiring an investment of just $0.19 PMPY by private health insurers.
Title. Costs to Private Insurers in Dubai for Vaccinating Non-Emirati Pregnant Women to Protect Infants Against Respiratory Syncytial Virus: a Modeling Study.
Summary. Respiratory syncytial virus (RSV) is a common cause of lower respiratory tract illness (LRTI; RSV-LRTI) among infants and young children. A new vaccine (herein “RSVpreF”) for pregnant women may reduce cases of RSV-LRTI as well as associated treatment costs among infants.
We used a Mic

许可

CC BY-NC-ND 4.0

引用

学术使用请引用 DOI 10.6084/m9.figshare.29458627.v1(source: https://tandf.figshare.com/articles/dataset/Budget_impact_of_maternal_vaccination_with_RSVpreF_to_protect_privately_insured_infants_in_Dubai_against_respiratory_syncytial_virus/29458627)。

数据缺失?

依托陕西、四川两大基地,我们与超过十家三甲医院建立直接合作关系,覆盖合规授权、采集治理、专业标注、数据交付的全流程,为AI医疗团队提供即拿即用的高质量临床数据。

⚡️ 需要数据支持或标注服务?立即联系我们获取专业方案。

获取专属数据定制方案